Skip to content

MBX Biosciences, Inc. MBX Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$3.76B+38.7%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$1.54B+390%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$14.4B+119%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.64B+40.1%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Enterprise value$2.16B+533%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Computed from the period-end share price: $1.42B.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s market capitalization?
MBX Biosciences, Inc. (MBX) reported market capitalization of $1.42B in Q1 2026.
How has MBX Biosciences, Inc.'s market capitalization changed year-over-year?
MBX Biosciences, Inc.'s market capitalization increased by 474.9% year-over-year, from $246.67M to $1.42B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.